The database software maker reported fiscal third-quarter earnings that failed to meet analysts' expectations and its shares fell more than 6% in extended trading.
The company did it.
According to the statement, revenue increased 4% from a year earlier. Net income fell to $2.32 billion.
Net income fell due to two investments. The company said profit was hurt by the tumbling share price of gene-sequencing company Oxford Nanopore and an operating loss at Arm server chip maker Ampere Computing.
We remain confident that our investments in these two cutting-edge technology companies will deliver very strong returns for us.
The company's short-term deferred revenue came in below the StreetAccount consensus.
In the quarter, Oracle announced its intent to acquire Cerner, a developer of software for managing health records, for $28.3 billion in cash.
The fiscal fourth quarter is expected to see 3% to 5% revenue growth, with adjusted earnings per share expected to be between $1.35 and $1.39. The analysts had been looking for revenue of $11.76 billion and a profit of $1.38 per share. The guidance does not include contributions from Safra Catz, the CEO of Oracle.
Executives will discuss the results with analysts on a conference call. Time.
The stock of Oracle was down 12% by the time of the after-hours move. The S&P 500 index has dropped over the last year.
This is breaking news. You can check back for updates.
Jim Cramer likes the stock of Oracle and it's trading at an amazing price.